USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports
USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports
NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Technavio's latest offering, the Extracorporeal Membrane Oxygenation Machines Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The extracorporeal membrane oxygenation machines market value is expected to grow by USD 239.83 million, progressing at a CAGR of 10.27% as per the latest report by Technavio.
紐約2021年11月29日/美通社/--Technavio的最新產品,體外膜氧合器市場報告詳細分析了各地區的競爭形勢和市場增長。預計體外膜氧合器市場價值將增長2.393億美元,以最快的速度前進複合年增長率為10.27%根據Technavio的最新報道。
For more insights on the Extracorporeal Membrane Oxygenation Machines Market - Download a free sample now!
有關體外膜氧合器市場的更多信息-立即下載免費樣本!
38% of the market's growth will originate from North America. US and Canada are the key markets for extracorporeal membrane oxygenation machines in the region. The rising number of new product launches will facilitate the extracorporeal membrane oxygenation machines market growth in North America
38%的市場增長將來自 北美。美國和加拿大是該地區體外膜氧合器的主要市場。不斷增加的新產品發佈將促進體外膜氧合器在北美的市場增長
Market Dynamics
市場動態
Factors such as the increasing incidence of respiratory and heart failure and the growing number of transplant procedures will drive the growth of the Extracorporeal Membrane Oxygenation Machines Market. However, high costs associated with cardiac and respiratory procedures might hamper the market growth.
一些因素,如呼吸和心力衰竭的發病率不斷增加,移植手術的數量也在不斷增加將推動體外膜氧合器市場的增長。然而,與心臟和呼吸手術相關的高成本可能會阻礙市場增長。
Company Profiles
公司概況
The extracorporeal membrane oxygenation machines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The extracorporeal membrane oxygenation machines market report includes information on the product launches, sustainability, and prospects of leading vendors including ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG, and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.
體外膜氧合器市場支離破碎供應商正在部署各種有機和無機增長戰略,以在市場上競爭。體外膜氧合器市場報告包括有關領先供應商的產品推出、可持續性和前景的信息,這些供應商包括ALung Technologies Inc.、Eurosets Srl、Fresenius Medical Care AG和Co.KGaA、Getinger AB、LivaNova Plc、美敦力、MicroPort Science Corp.、Nipro Corp.、Origen Biomedical Inc.和Terumo Corp.
Few Companies with Key Offerings
很少有公司提供關鍵產品
- ALung Technologies Inc. - The company offers extracorporeal membrane oxygenation machines that provide ultra low flow, venovenous extracorporeal carbon dioxide removal using a single, 15.5 French dual lumen catheter inserted percutaneously in the femoral or jugular vein and removes 25 to 50 percent of basal metabolic CO2 production at circuit blood flows of 350 to 550 mL per minute, under the brand name of Hemolung RAS.
- Eurosets Srl - The company offers extracorporeal membrane oxygenation machines that are designed to focus on optimal gas microemboli management and of its full coating with phosphorylcholine to work in a unique range of volumes, from less than 250 ml up to 2000 ml., under the brand name of Eurosets.
- Fresenius Medical Care AG and Co - The company offers extracorporeal membrane oxygenation machines that enable gas exchange and circulation, respectively, when standard treatment fails thus providing clinicians time to treat patients, under the brand name of Xenios.
- ALung Technologies Inc.-該公司提供的體外膜氧合器可提供超低流量、靜脈-靜脈體外二氧化碳清除服務,該設備使用一根15.5法國雙腔導管經皮插入股靜脈或頸靜脈,在循環血流量為350-550毫升/分鐘(品牌為Hemolung RAS)的情況下,可清除25%-50%的基礎代謝性二氧化碳產生量。
- Euroset Srl-該公司提供體外膜氧合器,其設計重點是優化氣體微栓子的治療,並用磷酰膽鹼進行全塗層,以Eurosets的品牌在不到250毫升到2000毫升的獨特體積範圍內工作。這款機器的設計重點是優化氣體微栓子的治療,並用磷酰膽鹼進行全塗層,使其在不到250毫升到2000毫升的獨特體積範圍內工作。
- 費森尤斯醫療保健股份公司(Fresenius Medical Care AG)該公司提供Xenios品牌的體外膜氧合器,當標準治療失敗時,該機器可以分別實現氣體交換和循環,從而為臨牀醫生提供治療患者的時間。
Competitive Analysis
競爭分析
The competitive scenario provided in the extracorporeal membrane oxygenation machines market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
體外膜氧合器市場報告中提供的競爭情景基於各種績效指標對公司進行分析、評估和定位。這項分析考慮的一些因素包括公司過去幾年的財務表現、增長戰略、產品創新、新產品的推出、投資、市場份額的增長等。
Market Segmentation
市場細分
- By Modality, the market is classified into Veno-venous and Veno-arterial. The extracorporeal membrane oxygenation machines' market share growth by the Veno-venous segment has been significant.
- By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
- 根據形態,市場分為靜脈-靜脈和靜脈-動脈。體外膜氧合器市場佔有率的增長靜脈-靜脈段意義重大。
- 根據地理位置,該市場被分類為北美, 歐洲, 亞洲,和划船。北美將擁有最大的市場份額。
Related Reports -
Neurodiagnostic and Monitoring Devices -The neurodiagnostic and monitoring devices market size in the US has the potential to grow by USD 443.81 million during 2020-2024.Download a free sample now!
相關報道-
神經診斷和監測設備-2020-2024年,美國的神經診斷和監測設備市場規模有可能增長4.4381億美元。立即下載免費樣本!
Chemiluminescence Immunoassay Analyzers Market -The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%. Download a free sample now!
化學發光免疫分析儀市場-從2021年到2026年,化學發光免疫分析(CLIA)分析儀的市場份額預計將增加32.4億美元,市場增長勢頭將以10.32%的複合年增長率加速。立即下載免費樣本!
Extracorporeal Membrane Oxygenation Machines Market Scope | |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.27% |
Market growth 2021-2025 |
USD 239.83 million |
Market structure |
Fragmented |
YoY growth (%) |
8.87 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Germany, UK, Canada, China, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
體外膜氧合器的市場範圍 | |
報告覆蓋範圍 |
細節 |
頁碼 |
120 |
基準年 |
2020 |
預測期 |
2021-2025 |
增長動能與複合年增長率 |
以10.27%的複合年均增長率加速 |
2021-2025年市場增長 |
2.393億美元 |
市場結構 |
支離破碎 |
同比增長(%) |
8.87 |
區域分析 |
北美、歐洲、亞洲和ROW |
表演市場貢獻 |
北美為38% |
主要消費國 |
美國、德國、英國、加拿大、中國和法國 |
競爭格局 |
領先公司、競爭戰略、消費者參與範圍 |
公司概況 |
阿隆技術公司、Eurosets Srl公司、費森尤斯醫療保健股份公司和KGaA公司、Getinger AB公司、LivaNova公司、美敦力公司、MicroPort科學公司、Nipro公司、Origen Biomedical公司和Terumo公司。 |
市場動態 |
母市場分析,市場增長誘因和障礙,快增長和慢增長細分市場分析,新冠肺炎影響和未來消費者動態,預測期市場狀況分析 |
定製權限 |
如果我們的報告沒有包括您正在尋找的數據,您可以聯繫我們的分析師並定製細分市場。 |
About Us
關於我們
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio是一家全球領先的技術研究和諮詢公司。他們的研究和分析側重於新興市場趨勢,並提供了可操作的見解,幫助企業識別市場機會並制定有效的戰略,以優化其市場地位。Technavio的報告庫擁有500多名專業分析師,由17000多份報告組成,並在不斷統計,涵蓋了橫跨50個國家和地區的800項技術。他們的客户羣包括各種規模的企業,其中包括100多家財富500強公司。不斷增長的客户基礎依賴於Technavio的全面覆蓋、廣泛的研究和可操作的市場洞察力,以確定現有和潛在市場中的機會,並評估它們在不斷變化的市場情景中的競爭地位。
Contact
聯繫人
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]Website: www.technavio.com/
技術研究
傑西·邁達
媒體與營銷主管
美國:+1 844 364 1100
英國:+44 203 893 3200
電子郵件:[受電子郵件保護]網站:Www.Technavio.com/
SOURCE Technavio
來源技術